BEAM
Price
$35.41
Change
+$0.86 (+2.49%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
3.51B
48 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.20
Change
+$0.03 (+2.56%)
Updated
Jan 14 closing price
Capitalization
68.1M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs TCRX

Header iconBEAM vs TCRX Comparison
Open Charts BEAM vs TCRXBanner chart's image
Beam Therapeutics
Price$35.41
Change+$0.86 (+2.49%)
Volume$34.45K
Capitalization3.51B
TScan Therapeutics
Price$1.20
Change+$0.03 (+2.56%)
Volume$487.62K
Capitalization68.1M
BEAM vs TCRX Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. TCRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (BEAM: $35.41 vs. TCRX: $1.20)
Brand notoriety: BEAM and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 122% vs. TCRX: 67%
Market capitalization -- BEAM: $3.59B vs. TCRX: $68.1M
BEAM [@Biotechnology] is valued at $3.59B. TCRX’s [@Biotechnology] market capitalization is $68.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • TCRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than TCRX.

Price Growth

BEAM (@Biotechnology) experienced а +22.40% price change this week, while TCRX (@Biotechnology) price change was +1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.51B) has a higher market cap than TCRX($68.1M). BEAM YTD gains are higher at: 24.639 vs. TCRX (17.000). TCRX has higher annual earnings (EBITDA): -136.89M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. TCRX (184M). TCRX has less debt than BEAM: TCRX (95.6M) vs BEAM (151M). BEAM has higher revenues than TCRX: BEAM (55.7M) vs TCRX (8.42M).
BEAMTCRXBEAM / TCRX
Capitalization3.51B68.1M5,148%
EBITDA-434.55M-136.89M317%
Gain YTD24.63917.000145%
P/E RatioN/AN/A-
Revenue55.7M8.42M661%
Total Cash1.08B184M584%
Total Debt151M95.6M158%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMTCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFNCF356.88N/A
N/A
Cie Financiere Tradition Lausanne ACT
ECLMF0.13N/A
N/A
Ecolomondo Corp.
NCRBF28.50N/A
N/A
Nippon Carbon Co., Ltd.
HRCR4009.00-7.01
-0.17%
Hershey Creamery Co.
BBSEY6.45-0.08
-1.23%
BB Seguridade Participacoes SA

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.55%
CRSP - BEAM
71%
Closely correlated
+1.59%
RXRX - BEAM
62%
Loosely correlated
-2.49%
NTLA - BEAM
61%
Loosely correlated
+2.71%
PRME - BEAM
59%
Loosely correlated
-2.80%
SYRE - BEAM
57%
Loosely correlated
-3.87%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
N/A
BMEA - TCRX
38%
Loosely correlated
+4.11%
BEAM - TCRX
38%
Loosely correlated
+2.55%
MGNX - TCRX
37%
Loosely correlated
-2.23%
KURA - TCRX
36%
Loosely correlated
+0.44%
XNCR - TCRX
36%
Loosely correlated
-1.62%
More